Efficacy, tolerability and safety of biologic therapy in rheumatoid disease: patient considerations.

Drug Healthc Patient Saf · 2010 · PMC3108701 · PMID 21701623

Europe PMC DOI

hedged sentence

0.1690

closest p · 3.4× alpha

0.1690

boldest claim

The sentences

did not reach statistical significanceP = 0.169not close (p > 0.1)

However, results did not reach statistical significance; mean change in total score in the rituximab group was 0.6 compared to 1.2 in controls ( P = 0.169).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.